AI assistant
PULSE BIOSCIENCES, INC. — Director's Dealing 2024
Aug 14, 2024
32093_dirs_2024-08-13_5bdeb95b-5db0-4f65-86b9-9ee411432ac5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PULSE BIOSCIENCES, INC. (PLSE)
CIK: 0001625101
Period of Report: 2024-08-09
Reporting Person: LAVIOLETTE PAUL A (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-08-09 | Stock Option (right to buy) | $15.65 | A | 50000 | Acquired | 2034-08-09 | Common Stock (50000) | Direct |
| 2024-08-09 | Stock Option (right to buy) | $15.65 | A | 200000 | Acquired | 2034-08-09 | Common Stock (200000) | Direct |
Footnotes
F1: One-third of the shares subject to the option will vest on the one-year anniversary of the grant and the remaining shares will vest on a monthly basis over two years thereafter, subject to the Reporting Person's continued service through each vesting date.
F2: One-fourth of the shares subject to the option will vest on the date of the Issuer's next annual meeting of stockholders and the remaining shares will vest on a monthly basis over three years thereafter, subject to the Reporting Person's continued service through each vesting date.